ICON plc (ICLR) During the most recent session, the shares traded at 0.82 points or 0.98% higher at $84.88. The money flow data is unimpressive with the net money flow value of $(-10.17) million. As per the intraday data, the upticks measured $8.12 million and the downticks measured $18.29 million. As a result, the up/down ratio registered a value of 0.44. The shares have seen 3.54% price change for the week.A block trade also made an entry with $1.86 million flowing in through upticks while $11.69 million flew out through downticks. The block tradeoff had the up/down ratio of 0.16. The net money flow for this big transaction was $(-9.83) million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Shares of ICON Public Limited Company rose by 4.39% in the last five trading days and 12.87% for the last 4 weeks. ICON Public Limited Company is up 5.73% in the last 3-month period. Year-to-Date the stock performance stands at 12.87%. ICON plc (NASDAQ:ICLR) rose 0.98% or 0.82 points on Wednesday and made its way into the gainers of the day. After trading began at $84.43 the stock was seen hitting $85.15 as a peak level and $83.54 as the lowest level. The stock ended up at $84.88. The daily volume was measured at 433,705 shares. The 52-week high of the share price is $85.74 and the 52-week low is $62.31. The company has a market cap of $4,702 million.
ICON PLC Last issued its quarterly earnings results on Oct 20, 2016. The company reported $1.19 EPS for the quarter, beating the analyst consensus estimate by $ 0.01. Analyst had a consensus of $1.18. The company had revenue of $420.20 million for the quarter, compared to analysts expectations of $419.53 million. The companys revenue was up 6.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.ICON PLC was Upgraded by Goldman to Buy on Dec 16, 2016. ICON PLC was Downgraded by SunTrust to Hold on Dec 16, 2016.
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.